MedTrace Logo

Effect of Injectable Platelet-rich Fibrin on Disc Displacement Without Reduction

NCT05640206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-12-08

No results posted yet for this study

Summary

This randomized clinical study was conducted on patients with disc displacement without reduction. Patient was selected one of the two study groups: control group received only arthrocentesis or test group received arthrocentesis + injectable platelet-rich fibrin (i-PRF). As primary outcome variable, pain was recorded at preoperatively and at postoperatively 1, 2, 3, 6 and 12 months. Maximum mouth opening, lateral and protrusive movements were formed as secondary outcome variables.

Conditions

  • Disc Disorder

Interventions

PROCEDURE

i-PRF

Arthrocentesis performed with two-needle technique, and then injection of i-PRF intra-articularly

PROCEDURE

Arthrocentesis

Arthrocentesis performed with two-needle technique

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Gözde Işık · Ege University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-07-01
Completion
2021-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05640206 on ClinicalTrials.gov